Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-31

Clinical Trial Update: ADVENT Post Approval Study

View source ↗

Summary

Boston Scientific's ADVENT Post Approval Study for paroxysmal atrial fibrillation is active but not recruiting, indicating ongoing follow-up without new enrollm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Paroxysmal Atrial Fibrillation | Status: ACTIVE_NOT_RECRUITING